In-depth characterization of a mouse model of post-traumatic epilepsy for biomarker and drug discovery
Abstract Post-traumatic epilepsy (PTE) accounts for 5% of all epilepsies and 10–20% of the acquired forms. The latency between traumatic brain injury (TBI) and epilepsy onset in high-risk patients offers a therapeutic window for intervention to prevent or improve the disease course. However, progres...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2021-04-01
|
| Series: | Acta Neuropathologica Communications |
| Online Access: | https://doi.org/10.1186/s40478-021-01165-y |